Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1250 | Obesity | ICEECE2012

Relationship between neck circumference and cardiometabolic parameters in non-obese brazilian adult population

Sales A. , Castelo M. , Ponte C. , Fernandes V. , Mendes P. , de Mesquita S. , Montenegro A. , Quidute A. , Negrato C. , Montenegro Jr R.

Recent studies have suggested that upper body adiposity is associated with major cardiovascular risk (CVR). However most of them were conducted in obese patients. This study aimed to evaluate the relationship of neck circumference (NC) in a non-obese Brazilian adult population, considering that it would be a simple and time-saving measurement to identify patients with worse cardiometabolic profile. We evaluated 279 non-obese Brazilian adults [86 men (♂), 193 women (&#979...

ea0020p131 | Thyroid | ECE2009

Regression of pulmonary arterial hypertension after treatment of hyperthyroidism

Quidute Ana Rosa , Paiva Joyce , Fernandes Virginia , Ponte Clarisse , Magalhaes Rejane , Montenegro Renan , Farias Ana Gardenia , Sobrinho Carlos Roberto Rodrigues , Junior Renan Montenegro

Several pathological processes contribute to the development and progression of pulmonary arterial hypertension (PAH), which is a disorder with high morbidity and mortality rates. However, although cardiac manifestations are common in hyperthyroidism (HT), they have been seldom described in association with HT. Thus, the objective of this study was to evaluate echocardiographic parameters in patients with Graves Disease (GD) during uncontrolled hyperthyroidism and after its re...

ea0081ep841 | Pituitary and Neuroendocrinology | ECE2022

Descriptive study of the acromegaly disease activity according to ACRODAT® in a tertiary Hospital in Spain

Carlos Percovich Hualpa Juan , Anez Roberto , Centeno Rogelio Garci a , Fernandez Laura Gonzalez , Munoz Diego , Montenegro Alejandra Maricel Rivas , Fernandez Fernandez Elisa , Guerrero Crystal , Gonzalez Albarran Olga

Background: The goals of acromegaly treatment are to achieve long-term biochemical control, control tumor size and decrease the risk of developing systemic comorbidities. Moreover, from the patient’s perspective, symptoms and QoL are critical parameters of disease control and should be assessed routinely. To aid in the global clinical management of acromegaly, a holistic clinical decision support tool, the Acromegaly Disease Activity Tool (ACRODAT®) was developed.</p...

ea0090ep306 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Maturity Onset Diabetes of the Young (MODY) associated with mutations in the Regulatory factor X6 (RFX6) gene: A case report

Piorno Alberto Garcia , Gata Isabel Losada , Anez Roberto , Rivas Montenegro Alejandra Maricel , Gonzalez Gloria Collado , Hernanz Monica Gomez-Gordo , Albarran Olga Gonzalez

Introduction: Maturity onset diabetes mellitus of the young (MODY) is a form of monogenic diabetes characterized by pancreatic B-cell dysfunction. The most common subtypes are caused by mutations in the genes encoding glucokinase (GCK) and hepatocyte nuclear factor (HNF1a, HNF4a), although unidentified genes are also involved. Regulatory factor X6 (RFX6) is a transcription factor gene which has an important biological role in B-cell formation and function. Biallelic mutations ...

ea0041ep328 | Clinical case reports - Thyroid/Others | ECE2016

Diabetic gastroparesis – a pregnancy in jeopardy

Magalhaes Daniela , Bettencourt-Silva Rita , Costa Maria Manuel , Saavedra Ana , Belo Sandra , Queiros Joana , Freitas Paula , Namora Gabriela , Montenegro Nuno , Carvalho Davide

Introduction: Diabetic gastroparesis (DGP) is defined by delayed gastric emptying in the absence of mechanical obstruction caused by autonomic neuropathy. Only 5% of type 1 and 1% of type 2 diabetic patients combine the delay of gastric emptying with typical gastroparesis symptoms. This entity is usually identified in patients with least 10 years of diabetes evolution and is presented typically in the 4th to 5th decades of life in type 1 diabetes mellitus (T1DM). It is associa...

ea0081ep695 | Pituitary and Neuroendocrinology | ECE2022

Epidemiological description of 20 years of experience in the management of insulinomas in a third level hospital

Maricel Rivas Montenegro Alejandra , Ramos Roberto Jose An ez , Belinchon Sergio Santos , Gonzalez Fernandez Laura , Moreno Diego Mun oz , Fernandez Fernandez Elisa , Salas Marcel Sambo , Hualpa Juan Carlos Percovich , Gonzalez Albarran Olga , Garcia Centeno Rogelio

Introduction: Insulinoma, despite its low incidence of 0.4%, it is the most common functioning pancreatic neuroendocrine tumor. Most are benign, solitary and sporadic. Around 10% can be malignant and 5-10% are part of MEN-1. On certain occasions, the differential diagnosis is difficult when there is a history of Diabetes Mellitus (DM). Our objective was to describe clinical-epidemiological data and its diagnostic-therapeutic management.Materials and Meth...

ea0086p343 | Neuroendocrinology and Pituitary | SFEBES2022

Variants in Methyl-CpG-binding protein 2 (MECP2) are associated with X-Linked Central Precocious Puberty

E Read Jordan , Pinheiro-Machado Canton Ana , Tinano Flavia , Guasti Leonardo , Ribeiro Montenegro Luciana , Ryan Fiona , Shears Deborah , Paganoni Alyssa , Korbonits Marta , Jorge Alexander , David Alessia , Bilharinho Mendonca Berenice , Nahime Brito Vinicius , Claudia Latronico Ana , Howard Sasha R

Whilst several key genetic contributors to the phenotype of central precocious puberty (CPP) have been recognized, many familial cases remain without a clear genetic aetiology. Methyl-CpG-binding protein 2 (MECP2) is a chromatin-associated transcriptional regulator, which plays an essential role in neuronal maturation. It is encoded by the MECP2 gene, located at chromosome Xq28, which is highly expressed in brain tissues. Loss-of-function mutations in MECP2 are usually associa...

ea0090ep686 | Pituitary and Neuroendocrinology | ECE2023

Inferior petrosal sinus sampling and stimulation with CRH: 18 years of experience in a tertiary hospital

Montenegro Alejandra Maricel Rivas , Anez Roberto , Gonzalez Fernandez Laura , Munoz Diego , Garcia Piorno Alberto , Losada Gata Isabel , Gomez-Gordo Hernanz Monica , Collado Gonzalez Gloria , Carlos Percovich Juan , Gonzalez Albarran Olga , Garcia Centeno Rogelio

Background: Inferior petrosal sinus sampling (IPSS) is indicated in the diagnosis of adrenocor-ticotropic hormone (ACTH)-dependent Cushing’s syndrome (CS), especially when the results of the initial diagnostic tests are discordant.Objective: To describe the patients who underwent this invasive functional test in a tertiary hospital.Methods: This was an observational study of a retrospective cohort of patients with ACTH- depend...

ea0070aep654 | Pituitary and Neuroendocrinology | ECE2020

Our experience with lu-dotatate in patients with neuroendocrine tumors in a tertiary hospital

Munoz Diego , Carlos Percovich Hualpa Juan , Weber Bettina , Atencia Goñi José , González Fernández Laura , Miguélez González María , Brox Torrecilla Noemí , José Añez Ramos Roberto , Maricel Rivas Montenegro Alejandra , López Guerra Aurelio , Lucía Olmedilla Isishi Yoko , Ángeles Vélez Romero María , Ágreda García Javier , Picallo Pérez María , Monereo Megías Susana , García Centeno Rogelio

Introduction: Lutetium-177-DOTATATE (Lu177) is approved in patients with well-differentiated (G1 and G2) neuroendocrine tumors (NETs) positive to somatostatin receptors, progressive and unresectable or metastatic. Lu177 has been shown to increase progression-free survival and the quality of life of these patients.Material and Methods: Retrospective descriptive study of a series of 15 cases with NETs treated with Lu177. Demographic data, tumor characteris...